(Total Views: 623)
Posted On: 11/23/2020 6:57:16 PM
Post# of 154066
In all fairness, we don't know what Dr Rugo has or has not contributed.
Quote:
I view this amfAR PR quite favorably. These types of indication-specific cooperative agreements will jump-start progress, while providing very good investor optics.
What I don't quite understand is why Dr. Hope Rugo has not been able to contribute a single mTNBC patient to our trial. I realize that's not specifically her job, but I would have thought she'd have a number of patients who could benefit.
Read More: https://investorshangout.com/post/view?id=597...z6efKLShBo
(1)
(0)
